Shrinivas Krishnarao Kulkarni
#134,987
Most Influential Person Now
Shrinivas Krishnarao Kulkarni's AcademicInfluence.com Rankings
Shrinivas Krishnarao Kulkarniphysics Degrees
Physics
#5594
World Rank
#7447
Historical Rank
Cosmology
#177
World Rank
#185
Historical Rank
Astrophysics
#400
World Rank
#439
Historical Rank
Astronomy
#730
World Rank
#1298
Historical Rank
Download Badge
Physics
Shrinivas Krishnarao Kulkarni's Degrees
- PhD Astronomy University of California, Berkeley
Why Is Shrinivas Krishnarao Kulkarni Influential?
(Suggest an Edit or Addition)Shrinivas Krishnarao Kulkarni's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Withania somnifera: An Indian ginseng (2008) (323)
- Memory enhancing activity of Glycyrrhiza glabra in mice. (2004) (302)
- CURCUMIN, THE ACTIVE PRINCIPLE OF TURMERIC (CURCUMA LONGA), AMELIORATES DIABETIC NEPHROPATHY IN RATS (2006) (302)
- Antidepressant activity of curcumin: involvement of serotonin and dopamine system (2008) (291)
- Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes (2009) (238)
- Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging- and dizocilpine-induced learning impairment (1998) (228)
- Nitric oxide and major depression. (2011) (192)
- Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF‐alpha (2007) (186)
- On the mechanism of antidepressant-like action of berberine chloride. (2008) (185)
- Evaluation of learning and memory mechanisms employing elevated plus-maze in rats and mice (1992) (184)
- Resveratrol, a Polyphenolic Phytoalexin, Attenuates Diabetic Nephropathy in Rats (2006) (166)
- Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice (1997) (164)
- Minocycline prevents the development of neuropathic pain, but not acute pain: possible anti-inflammatory and antioxidant mechanisms. (2008) (139)
- Antinociceptive and anti-inflammatory effects of Tanacetum parthenium L. extract in mice and rats. (1999) (137)
- Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome. (2002) (135)
- Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms. (2011) (134)
- Sigma (σ1) receptor mediated antidepressant‐like effects of neurosteroids in the Porsolt forced swim test (1998) (133)
- Molecular interactions of ethanol with GABAergic system and potential of RO15–4513 as an ethanol antagonist (1988) (133)
- Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain (2008) (131)
- On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor (2001) (131)
- Animal behavioral models for testing antianxiety agents. (1996) (130)
- Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor. (2007) (129)
- Possible antioxidant mechanism in melatonin reversal of aging and chronic ethanol-induced amnesia in plus-maze and passive avoidance memory tasks. (2001) (129)
- Sildenafil-induced peripheral analgesia and activation of the nitric oxide–cyclic GMP pathway (2001) (120)
- Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride. (2007) (120)
- Protective Effect of Flavonoids against Aging- and Lipopolysaccharide-Induced Cognitive Impairment in Mice (2003) (117)
- Effect of various classes of antidepressants in behavioral paradigms of despair (2007) (111)
- Improvement of mouse memory by Myristica fragrans seeds. (2004) (109)
- Reversal of Aging and Chronic Ethanol-induced Cognitive Dysfunction by Quercetin a Bioflavonoid (2003) (105)
- Sex and Estrous Cycle-Dependent Changes in Neurosteroid and Benzodiazepine Effects on Food Consumption and Plus-Maze Learning Behaviors in Rats (1999) (103)
- Melatonin reversal of lipopolysacharides-induced thermal and behavioral hyperalgesia in mice. (2000) (101)
- Involvement of l-arginine–nitric oxide–cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice (2007) (100)
- Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia (2003) (99)
- Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation (2000) (98)
- Purine nucleoside — mediated immobility in mice: Reversal by antidepressants (2004) (96)
- Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors. (2000) (95)
- The effects of neurosteroids on acquisition and retention of a modified passive-avoidance learning task in mice (1998) (92)
- Carvedilol attenuates neuroleptic‐induced orofacial dyskinesia: possible antioxidant mechanisms (2002) (91)
- Effect of resveratrol, a polyphenolic phytoalexin, on thermal hyperalgesia in a mouse model of diabetic neuropathic pain (2007) (89)
- Elevated zero maze: a paradigm to evaluate antianxiety effects of drugs. (2007) (88)
- Modulatory role of cyclooxygenase inhibitors in aging- and scopolamine or lipopolysaccharide-induced cognitive dysfunction in mice (2002) (87)
- Modulatory effect of sildenafil in diabetes and electroconvulsive shock-induced cognitive dysfunction in rats. (2006) (85)
- The role of GABA-A and mitochondrial diazepam-binding inhibitor receptors on the effects of neurosteroids on food intake in mice (1998) (84)
- Melatonin enhances Th2 cell mediated immune responses: Lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists (2001) (81)
- Inhibition of morphine tolerance and dependence by Withania somnifera in mice. (1997) (81)
- Isobolographic analysis of interaction between cyclooxygenase inhibitors and tramadol in acetic acid-induced writhing in mice (2004) (79)
- Effect of Withania somnifera root extract on reserpine‐induced orofacial dyskinesia and cognitive dysfunction (2006) (79)
- Neuroprotective effect of nimesulide, a preferential COX-2 inhibitor, against pentylenetetrazol (PTZ)-induced chemical kindling and associated biochemical parameters in mice (2007) (79)
- Studies on modulation of feeding behavior by atypical antipsychotics in female mice (2002) (79)
- Effect of Withania somnifera root extract on haloperidol-induced orofacial dyskinesia: possible mechanisms of action. (2003) (78)
- Pharmacological profile of parecoxib: a novel, potent injectable selective cyclooxygenase-2 inhibitor. (2004) (77)
- Role of cysteinyl leukotrienes in nociceptive and inflammatory conditions in experimental animals. (2001) (77)
- Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)-induced convulsions: Possible mechanism of action (2006) (77)
- Role of GABA-A and mitochondrial diazepam binding inhibitor receptors in the anti-stress activity of neurosteroids in mice (1996) (76)
- Comparative brain cholinesterase-inhibiting activity of Glycyrrhiza glabra, Myristica fragrans, ascorbic acid, and metrifonate in mice. (2006) (75)
- Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes. (2006) (74)
- Pathophysiology and drug therapy of tardive dyskinesia: current concepts and future perspectives. (2003) (74)
- Current investigational drugs for major depression (2009) (73)
- Modulation of NSAID-induced antinociceptive and anti-inflammatory effects by alpha2-adrenoceptor agonists with gastroprotective effects. (2002) (71)
- Reversal of Reserpine-Induced Orofacial Dyskinesia and Cognitive Dysfunction by Quercetin (2004) (68)
- Protective effect of naproxen (non-selective COX-inhibitor) or rofecoxib (selective COX-2 inhibitor) on immobilization stress-induced behavioral and biochemical alterations in mice. (2006) (66)
- Curcumin pretreatment protects against acute acrylonitrile-induced oxidative damage in rats. (2010) (66)
- Phosphodiesterase 5 enzyme and its inhibitors: update on pharmacological and therapeutical aspects. (2004) (65)
- Comparison of anticonvulsant effect of ethanol against NMDA-, kainic acid- and picrotoxin-induced convulsions in rats. (1990) (65)
- Effect of Withania somnifera Dunal root extract against pentylenetetrazol seizure threshold in mice: possible involvement of GABAergic system. (2008) (63)
- Licofelone--a novel analgesic and anti-inflammatory agent. (2007) (63)
- Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor increases pentylenetetrazol seizure threshold in mice: Possible involvement of adenosinergic mechanism (2008) (63)
- Chronic neurosteroid treatment prevents the development of morphine tolerance and attenuates abstinence behavior in mice. (1997) (62)
- Proconvulsant effects of neurosteroids pregnenolone sulfate and dehydroepiandrosterone sulfate in mice. (1998) (60)
- Protective effect of rutin, a polyphenolic flavonoid against haloperidol‐induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes (2007) (59)
- New drug metabolism inhibitor of marine origin. (1978) (58)
- Anti-inflammatory actions of clonidine, guanfacine and B-HT 920 against various inflammagen-induced acute paw oedema in rats. (1986) (57)
- Effect of alpha2 agonists clonidine, guanfacine and B-HT 920 on gastric acid secretion and ulcers in rats. (1985) (57)
- Memory-strengthening activity of Glycyrrhiza glabra in exteroceptive and interoceptive behavioral models. (2004) (56)
- Sildenafil, a Phosphodiesterase-5 Inhibitor, Enhances the Antinociceptive Effect of Morphine (2003) (55)
- Effect of Addition of Yohimbine (Alpha-2-Receptor Antagonist) to the Antidepressant Activity of Fluoxetine or Venlafaxine in the Mouse Forced Swim Test (2007) (54)
- Quercetin Potentiates L-Dopa Reversal of Drug-Induced Catalepsy in Rats: Possible COMT/MAO Inhibition (2003) (54)
- σ-1 receptors in major depression and anxiety (2009) (53)
- Development of neurosteroid-based novel psychotropic drugs. (2000) (53)
- Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements. (2001) (51)
- Modulatory Effect of the PDE-5 Inhibitor Sildenafil in Diabetic Neuropathy (2004) (51)
- Effect of nimesulide on acetic acid- and leukotriene-induced inflammatory bowel disease in rats. (2003) (51)
- Reversal of morphine tolerance and dependence by melatonin: possible role of central and peripheral benzodiazepine receptors (1999) (51)
- 5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion. (1998) (50)
- Involvement of dopamine (DA)/serotonin (5-HT)/sigma (σ) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist (2007) (50)
- Evidence for GABA-BZ receptor modulation in short-term memory passive avoidance task paradigm in mice. (1990) (50)
- Possible mechanism of action in melatonin attenuation of haloperidol-induced orofacial dyskinesia (2003) (50)
- Nitric oxide signaling pathway in the anti-convulsant effect of adenosine against pentylenetetrazol-induced seizure threshold in mice. (2008) (48)
- Comparative behavioural profile of newer antianxiety drugs on different mazes. (2008) (48)
- Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: Possible involvement of alpha-2 adrenergic receptors (2008) (45)
- Neurosteroid coadministration prevents development of tolerance and augments recovery from benzodiazepine withdrawal anxiety and hyperactivity in mice. (1997) (45)
- Antidepressant-like effect of 17beta-estradiol: involvement of dopaminergic, serotonergic, and (or) sigma-1 receptor systems. (2008) (45)
- Lipopolysaccharide-mediated immobility in mice: reversal by cyclooxygenase enzyme inhibitors. (2001) (45)
- Melatonin reversal of DOI-induced hypophagia in rats; possible mechanism by suppressing 5-HT2A receptor-mediated activation of HPA axis (2000) (45)
- Significantly higher serologic responses of Chlamydia trachomatis B group serovars versus C and I serogroups. (2009) (45)
- Clonidine — induced behavioural despair in mice: Reversal by antidepressants (2004) (44)
- Evaluation of anti-hyperglycemic activity of some novel monocyclic beta lactams. (2004) (44)
- Possible mechanisms of action in melatonin reversal of morphine tolerance and dependence in mice. (2000) (44)
- Venlafaxine reverses chronic fatigue-induced behavioral, biochemical and neurochemical alterations in mice (2008) (43)
- Antiobesity effect of a polyherbal formulation, OB-200G in female rats fed on cafeteria and atherogenic diets. (2000) (43)
- EFFECT OF NAPROXEN, A NON‐SELECTIVE CYCLO‐OXYGENASE INHIBITOR, ON PENTYLENETETRAZOL‐INDUCED KINDLING IN MICE (2005) (43)
- Elevated plus-maze: a novel psychobehavioral tool to measure anxiety in rodents. (1991) (42)
- Effect of combination of insulin with dextrose, D(-) fructose and diet on learning and memory in mice (2003) (42)
- Protective Effect of Curcumin and its Combination with Piperine (Bioavailability Enhancer) Against Haloperidol-Associated Neurotoxicity: Cellular and Neurochemical Evidence (2011) (41)
- Effect of various antiepileptic drugs in a pentylenetetrazol-induced seizure model in mice. (2009) (40)
- Protective effect of quercetin on alcohol abstinence-induced anxiety and convulsions. (2005) (40)
- Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia—A biochemical and neurochemical study (2007) (40)
- Protective effects of nimesulide (COX Inhibitor), AKBA (5-LOX Inhibitor), and their combination in aging-associated abnormalities in mice. (2005) (39)
- Protective effect of cyclooxygenase‐2 (COX‐2) inhibitors but not non‐selective cyclooxygenase (COX)‐inhibitors on ethanol withdrawal‐induced behavioural changes (2005) (38)
- Evidence for nootropic effect of BR-16A (Mentat), a herbal psychotropic preparation, in mice. (1992) (38)
- Involvement of sigma-1 receptor modulation in the antidepressant action of venlafaxine (2007) (37)
- GABA receptor mediated anticonvulsant action of Withania somnifera root extract (1993) (37)
- Preferential inhibition of dizocilpine-induced hyperlocomotion by olanzapine. (1999) (36)
- Reversal of reserpine-induced vacuous chewing movements in rats by melatonin: involvement of peripheral benzodiazepine receptors (2001) (36)
- Theophylline, adenosine receptor antagonist prevents behavioral, biochemical and neurochemical changes associated with an animal model of tardive dyskinesia. (2007) (36)
- Co-Administration of Acetyl-11-Keto-β-Boswellic Acid, a Specific 5-Lipoxygenase Inhibitor, Potentiates the Protective Effect of COX-2 Inhibitors in Kainic Acid-Induced Neurotoxicity in Mice (2006) (36)
- Cyclooxygenase in epilepsy: from perception to application. (2009) (35)
- Fluoxetine suppresses morphine tolerance and dependence: modulation of NO-cGMP/DA/serotoninergic pathways. (2003) (34)
- Aggravation of Inflammatory Bowel Disease by Cyclooxygenase-2 Inhibitors in Rats (2004) (34)
- Possible antioxidant and neuroprotective mechanisms of FK506 in attenuating haloperidol-induced orofacial dyskinesia. (2003) (34)
- Cholinergic-NO-cGMP mediation of sildenafil-induced antinociception. (2004) (34)
- Effect of selective inhibition of cyclooxygenase-2 on lipopolysaccharide-induced hyperalgesia (2004) (33)
- Differential effects of naproxen and rofecoxib on the development of hypersensitivity following nerve injury in rats (2004) (33)
- Possible mechanisms of action in quercetin reversal of morphine tolerance and dependence (2003) (33)
- Protective effect of Withania somnifera root extract on electrographic activity in a lithium‐pilocarpine model of status epilepticus (1998) (33)
- Effects of MK-801 and ketamine on short-term memory deficits in passive avoidance step-down task paradigm in mice. (1991) (33)
- Possible involvement of nitric oxide (NO) signaling pathway in the antidepressant-like effect of MK-801(dizocilpine), a NMDA receptor antagonist in mouse forced swim test. (2008) (32)
- Quercetin, a bioflavonoid, reverses haloperidol-induced catalepsy. (2004) (32)
- Targeting oxidative stress, mitochondrial dysfunction and neuroinflammatory signaling by selective cyclooxygenase (COX)-2 inhibitors mitigates MPTP-induced neurotoxicity in mice (2011) (32)
- METHODS AND CONSIDERATIONS FOR EXPERIMENTAL EVALUATION OF ANTIEPILEPTIC DRUGS. (1999) (31)
- Anticonvulsant Action of Withania somnifera (Aswaganda) Root Extract against Pentylenetetrazol‐induced Kindling in Mice (1996) (31)
- Involvement of adenosinergic receptors in anxiety related behaviours. (2007) (31)
- Sigma (sigma1) receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt forced swim test. (1998) (31)
- Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats (2008) (30)
- Reversal of benzodiazepine inverse agonist FG 7142-induced anxiety syndrome by neurosteroids in mice. (1997) (30)
- Effect of cyclooxygenase-2 (COX-2) inhibitors in various animal models (bicuculline, picrotoxin, maximal electroshock-induced convulsions) of epilepsy with possible mechanism of action. (2006) (30)
- Interaction between GABAergic anticonvulsants and the NMDA receptor antagonist MK 801 against MES- and picrotoxin-induced convulsions in rats. (1989) (29)
- Possible involvement of sigma‐1 receptors in the anti‐immobility action of bupropion, a dopamine reuptake inhibitor (2008) (29)
- Current investigational drugs for major depression. (2009) (29)
- Analgesic, Anti‐inflammatory and Ulcerogenic activity of a Zinc‐Naproxen Complex in Mice and Rats (1999) (29)
- Differential role of dopamine receptor subtypes in thermoregulation and stereotypic behavior in naive and reserpinized rats. (1993) (29)
- Modulatory Effect of Cyclooxygenase Inhibitors on Sildenafil-Induced Antinociception (2003) (28)
- Possible involvement of prostaglandins in haloperidol-induced orofacial dyskinesia in rats. (2001) (28)
- Positioning dual inhibitors in the treatment of pain and inflammatory disorders (2008) (28)
- D2-dopamine receptor and alpha2-adrenoreceptor-mediated analgesic response of quercetin. (2003) (28)
- Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor potentiates the anticonvulsant activity of tiagabine against pentylenetetrazol-induced convulsions in mice (2006) (27)
- Co-administration of nitric oxide (NO) donors prevents haloperidol-induced orofacial dyskinesia, oxidative damage and change in striatal dopamine levels (2009) (27)
- Pharmacodynamics of drug-induced weight gain. (2001) (27)
- Central nervous system depressant activities of melatonin in rats and mice. (1998) (27)
- Licofelone: The answer to unmet needs in osteoarthritis therapy? (2008) (27)
- Protective effect of BR-16A (Mentat), a herbal preparation on alcohol abstinence-induced anxiety and convulsions. (1993) (26)
- In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration. (2009) (26)
- Effect of Curcumin Against Pentylenetetrazol‐Induced Seizure Threshold in Mice: Possible Involvement of Adenosine A1 Receptors (2014) (26)
- Evidence for serotonergic modulation of progesterone-induced hyperphagia, depression and algesia in female mice (2002) (26)
- Protective Effect of L-type Calcium Channel Blockers Against Haloperidol-induced Orofacial Dyskinesia: A Behavioural, Biochemical and Neurochemical Study (2008) (26)
- Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia. (2007) (26)
- Protective effect of FK506 (Tacrolimus) in pentylenetetrazol-induced kindling in mice (2003) (25)
- Differential effect of zileuton, a 5-lipoxygenase inhibitor, against nociceptive paradigms in mice and rats (2005) (25)
- Resveratrol, a polyphenolic phytoalexin attenuates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rats. (2006) (25)
- Differential striatal levels of TNF-α, NFκB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: Role in orofacial dyskinesia (2008) (24)
- Effect of a herbal psychotropic preparation, BR-16A (Mentat), on performance of mice on elevated plus-maze. (1991) (24)
- Modification of drug-induced catatonia and tremors by quapazine in rats and mice. (1980) (24)
- Role of D1/D2 dopamine and N-methyl-d-aspartate (NMDA) receptors in morphine tolerance and dependence in mice (1995) (24)
- Protective effect of BR‐16A, a polyherbal preparation against social isolation stress: possible GABAergic mechanism (2006) (24)
- Pharmacotherapy of male erectile dysfunction with sildenafil (1998) (24)
- Role of centrally administered melatonin and inhibitors of COX and NOS in LPS-induced hyperthermia and adipsia. (1999) (24)
- Studies with {α2}-adrenoceptor agonists and alcohol abstinence syndrome in rats (2004) (23)
- Activation of striatal inflammatory mediators and caspase-3 is central to haloperidol-induced orofacial dyskinesia. (2008) (23)
- Animal models of tardive dyskinesia--a review. (2001) (22)
- Peripheral and central activation of nitric oxide-cyclic GMP pathway by sildenafil (2006) (22)
- Dopamine D4 receptors and development of newer antipsychotic drugs (2000) (22)
- Anti‐inflammatory effect of licofelone against various inflammatory challenges (2006) (22)
- Potentiation of antinociceptive effect of NSAIDs by a specific lipooxygenase inhibitor, acetyl 11-keto-beta boswellic acid. (2006) (22)
- MK‐801 produces antianxiety effect in elevated plus‐maze in mice (1991) (22)
- GABA-mediated modification of despair behavior in mice (2004) (21)
- Effect of rofecoxib, a cyclo‐oxygenase‐2 inhibitor, on various biochemical parameters of brain associated with pentylenetetrazol‐induced chemical kindling in mice (2006) (21)
- (+/-)Baclofen sensitive scopolamine-induced short-term memory deficits in mice. (1993) (21)
- Prevention of development of tolerance and dependence to opiate in mice by BR-16A (Mentat), a herbal psychotropic preparation. (1992) (20)
- RO15-4513 but not FG-7142 reverses anticonvulsant effects of ethanol against bicuculline- and picrotoxin-induced convulsions in rats (1989) (20)
- Effect of licofelone against NSAIDs-induced gastrointestinal ulceration and inflammation. (2005) (20)
- Modulatory effect of neurosteroids in haloperidol-induced vacuous chewing movements and related behaviors (2008) (20)
- Comparative Study of Antidepressants and Herbal Psychotropic Drugs in a Mouse Model of Chronic Fatigue (2000) (19)
- On the safety of nimesulide, a preferential COX-2 inhibitor (2002) (19)
- Analgesic and anti-inflammatory effects of phosphodiesterase inhibitors. (2000) (19)
- Involvement of peripheral prostaglandins in formalin-induced nociceptive behaviours in the orofacial area of rats (2006) (18)
- Gastric antiulcer activity of UL-409 in rats. (1996) (18)
- Effect of systemic administration of adenosine on brain adenosine levels in pentylenetetrazol-induced seizure threshold in mice (2007) (18)
- Effect of zileuton in radicular pain induced by herniated nucleus pulposus in rats (2004) (18)
- Antianxiety profile of ondansetron, a selective 5-HT3 antagonist, in a novel animal model. (1997) (18)
- Partial agonistic action of clozapine at dopamine D2 receptors in dopamine depleted animals (1998) (18)
- Reversal of neuroleptic-induced orofacial dyskinesia by 5-HT3 receptor antagonists. (2001) (18)
- Analgesic activity of acetyl-11-keto-beta-boswellic acid, a 5-lipoxygenase-enzyme inhibitor (2005) (18)
- Development and validation of an RP-HPLC method for the estimation of adenosine and related purines in brain tissues of rats. (2008) (18)
- Evidence for benzodiazepine receptor interaction with MK 801 in anxiety related behaviour in rats. (1993) (18)
- Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABAA modulating neurosteroid (2008) (17)
- Clozapine-induced cognitive dysfunction in mice. (1996) (17)
- Systemic administration of adenosine ameliorates pentylenetetrazol‐induced chemical kindling and secondary behavioural and biochemical changes in mice (2007) (17)
- PASS assisted search and evaluation of some azetidin-2-ones as C.N.S. active agents. (2005) (17)
- Dopamine receptor sensitive effect of dizocilpine on feeding behaviour (1998) (17)
- Pharmacological studies on nitro‐naproxen (naproxen‐2‐nitrooxyethylester) (2004) (17)
- Differential effects of olanzapine at dopamine D1 and D2 receptors in dopamine depleted animals (1999) (17)
- Modulatory role of GABA receptor subtypes and glutamate receptors in the anticonvulsant effect of barbiturates. (1992) (17)
- ANANDAMIDE : AN ENDOGENOUS CANNABINOID (1996) (16)
- Protective effect of bupropion on morphine tolerance and dependence in mice. (2004) (16)
- Effect of 5-lipoxygenase inhibition on events associated with inflammatory bowel disease in rats. (2004) (16)
- Effects of ondansetron on short-term memory retrieval in mice. (1997) (16)
- Subchronic studies on modulation of feeding behavior and body weight by neurosteroids in female mice. (2001) (16)
- Prevention of morphine discontinuation phenomenon in mice by ondansetron, a selective 5-HT3 antagonist. (1996) (16)
- Sildenafil induces hyperalgesia via activation of the NO-cGMP pathway in the rat neuropathic pain model (2006) (16)
- Modulation of MK-801 response by dopaminergic agents in mice (2005) (16)
- Failure of FK506 (tacrolimus) to alleviate apomorphine-induced circling in rat Parkinson model in spite of some cytoprotective effects in SH-SY5Y dopaminergic cells (2005) (15)
- Investigations on possible serotonergic involvement in effects of OB-200G (polyherbal preparation) on food intake in female mice (2001) (15)
- Differential effects of cyclooxygenase inhibitors on haloperidol-induced catalepsy (2002) (15)
- Actions of clonidine on convulsions and behaviour. (1981) (15)
- Effect of olanzapine on behavioural changes induced by FG 7142 and dizocilpine on active avoidance and plus maze tasks (1999) (15)
- GABAergic agents-induced antinociceptive effect in mice. (1989) (15)
- Inhibitory effect of sildenafil on gastrointestinal smooth muscle: role of NO-cGMP transduction pathway. (2005) (15)
- Dizocilpine, ketamine and ethanol reverse NMDA-induced EEG changes and convulsions in rats and mice. (1991) (14)
- Reversal by alpha-2 agonists of diazepam withdrawal hyperactivity in rats (2004) (14)
- Antagonistic Activity of Ascorbic Acid (Vitamin C) on Dopaminergic Modulation: Apomorphine-Induced Stereotypic Behavior in Mice (2006) (14)
- Paradoxical Effects of Opioid Antagonist Naloxone on SSRI-Induced Analgesia and Tolerance in Mice (2003) (14)
- Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA antagonist MK-801. (1998) (14)
- Effect of baclofen, a GABAB-agonist, on forced swimming-induced immobility in mice. (1990) (13)
- Role of adenosine in drug-induced catatonia in mice. (2002) (13)
- Reversal of haloperidol-induced orofacial dyskinesia by quercetin, a bioflavonoid (2003) (13)
- Evidence of beta-adrenergic involvement in forced swimming-induced behavioural despair of mice. (1987) (13)
- Clonidine in alcohol withdrawal: a clinical report. (1987) (12)
- Effect of licofelone against mechanical hyperalgesia and cold allodynia in the rat model of incisional pain. (2005) (12)
- Novel substances of marine origin as drug metabolism inhibitors (1978) (12)
- Differential effect of a polyherbal formulation-OB-200G in male and female mice subjected to forced swim stress. (2000) (12)
- Modulatory role of D-1 and D-2 dopamine receptor subtypes in nociception in mice (1993) (12)
- D1/D2 dopamine and N-methyl-d-aspartate (NMDA) receptor participation in experimental catalepsy in rats (2005) (12)
- Simple ammonium salts acting on sigma-1 receptors yield potential treatments for cancer and depression (2020) (12)
- Chronic benzodiazepine antagonist treatment and its withdrawal upregulates components of GABA-benzodiazepine receptor ionophore complex in cerebral cortex of rat (1990) (12)
- A simple technique to evaluate inflammatory pain along with anti-inflammatory studies in carrageenan-induced paw edema (2001) (12)
- Involvement of central type benzodiazepine and GABAA receptor in the protective effect of benzodiazepines in stress-induced gastric ulcers in rats. (1987) (12)
- Reversal of diazepam withdrawal induced hyperactivity in mice by BR 16-A (Mentat), a herbal preparation. (1994) (12)
- Differential effect of the PDE5 inhibitors, sildenafil and zaprinast, in aging‐ and lipopolysaccharide‐induced cognitive dysfunction in mice (2004) (11)
- GABAergic, dopaminergic and cholinergic interactions in perphenazine-induced catatonia in rats. (1985) (11)
- Reversal by serotonergic agents of reserpine-induced hyperalgesia in rats. (1982) (11)
- Evidence of GABAergic modulation in melatonin-induced short-term memory deficits and food consumption. (1998) (11)
- Studies with alpha 2-adrenoceptor agonists and alcohol abstinence syndrome in rats. (1986) (11)
- Possible analgesic and anti-inflammatory interactions of aspartame with opioids and NSAIDs. (2005) (11)
- Quercetin, a bioflavonoid, reverses development of tolerance and dependence to morphine (2002) (11)
- Rofecoxib potentiates the anticonvulsant effect of topiramate (2008) (11)
- Pro-convulsant effect of cefazolin sodium against pentylenetetrazol- or picrotoxin-induced convulsions in mice. (2007) (10)
- Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics. (1999) (10)
- Licofelone attenuates MPTP-induced neuronal toxicity: behavioral, biochemical and cellular evidence (2010) (10)
- Relative Role of Cyclooxygenase-2 (COX-2) Inhibitors and Lipoxygenase (LOX) Inhibitors in Aging Induced Dementia and Oxidative Damage (2005) (10)
- Medicinal plants and memory (2003) (9)
- Protective effect of clozapine against pentylenetetrazol convulsions and kindling. (1998) (9)
- P-1 purinoceptor antagonism by clonidine in the rat caecum. (1984) (9)
- Dopamine Receptor Mediated Hypothermic Action of B‐HT 920 in Rats (1991) (9)
- L-NAME, a nitric oxide synthase inhibitor, modulates cholinergic antinociception. (1999) (9)
- Analysis of interaction between etoricoxib and tramadol against mechanical hyperalgesia of spinal cord injury in rats. (2006) (9)
- Apparent pA2 estimation of benzodiazepine receptor antagonists. (1986) (9)
- NEUROPROTECTIVE EFFECTS OF NEUROSTEROIDS AGAINST HYPOXIC-NEUROTOXICITY IN NAIVE AND BENZODIAZEPINE INVERSE AGONIST FG 7142-TREATED MICE (1997) (9)
- Effect of FK506 (tacrolimus) in animal models of inflammation (2004) (9)
- Antagonism by pimozide of olanzapine‐induced hypothermia (1999) (8)
- Effect of venoruton on hypoxic stress-induced neurotoxicity in mice and oxygen free radical generation by human neutrophils. (1989) (8)
- Naloxone-sensitive and GABAA receptor mediated analgesic response of benzodiazepines in mice. (1987) (8)
- Hypoxic stress-induced convulsion and death: protective effect of alpha 2-adrenoceptor and benzodiazepine receptor agonists and Ro 5-4864. (1988) (8)
- Reversal of Triazolam Tolerance and Withdrawal-Induced Hyperlocomotor Activity and Anxiety by Bupropion in Mice (2005) (8)
- Concomitant D1 dopamine receptor activation (SKF 38393) unmasks D2 dopaminergic actions of B-HT 920 in mice. (1991) (8)
- Protective Effect of Adenosine Reuptake Inhibitors in Haloperidol-Induced Orofacial Dyskinesia and Associated Behavioural, Biochemical and Neurochemical Changes (2007) (8)
- Coxibs: The new super aspirins or unsafe pain killers? (2005) (8)
- Clozapine: partial agonist at dopamine D2 receptors! (1998) (8)
- Animal models of tardive dyskinesia. (2011) (8)
- AT1 receptor antagonism enhances angiotensin-II-facilitated carrageenan-induced paw edema. (2000) (7)
- Antinociceptive effect of sumatriptan in mice. (1998) (7)
- Current concepts in the molecular diversity and pharmacology of dopamine receptors. (1996) (7)
- Modification by levo-propranolol of tremors induced by harmine in mice (1979) (7)
- Differential effect of polyherbal, antiobesity preparation, OB-200G in male and female mice and monosodium glutamate-treated rats. (2001) (7)
- SELECTIVE ALPHA2: ADRENOCEPTOR BLOCKADE PRODUCES ANTIDEPRESSANT EFFECT IN MICE (1998) (7)
- Antagonism of caffeine-induced convulsions by ethanol and dizocilpine (MK-801) in mice. (1991) (7)
- Role of cyclooxygenase-2 in lipopolysaccharide-induced hyperalgesia in formalin test. (2005) (7)
- FK506 as effective adjunct to L-dopa in reserpine-induced catalepsy in rats. (2003) (7)
- Inhibition of neuronal nitric oxide synthase (n-cNOS) reverses the corticotrophin-induced behavioral effects in rats (1998) (7)
- Facilitation of diazepam action by anticonvulsant agents against picrotoxin induced convulsions (2004) (7)
- Acute studies on safety index of nonsteroidal anti-inflammatory drugs in rats (2001) (7)
- Inhibition of COX-1 enzyme potentiates opioid-induced antinociception in animal model of central nociception (2003) (6)
- Ketanserin reverses dizocilpine-suppression of morphine dependence but not tolerance in mice (2000) (6)
- Effect of 5-lipoxygenase inhibitor against lipopolysaccharide-induced hypothermia in mice. (2005) (6)
- Dopamine receptor mediated antidepressant action of B-HT 920 in mice. (1994) (6)
- ANTISPASMODIC ACTIVITY OF DICLOFENAC AND ITS COMBINATION WITH PITOFENONE AND FENPIVERINIUM ON RAT COLON (1998) (6)
- Some non cardiovascular actions of clonidine (1984) (6)
- Synthesis and pharmacological evaluation of some quinoline derivatives as Potential antiamnesic agents (2009) (6)
- Fluoxetine, a selective serotonin reuptake inhibitor modulates inflammatory and neuropathic pain in the rat (2001) (5)
- Effect of withdrawal of diazepam or morphine treatment on gastric motility (charcoal meal test) in mice: possible role of different central and peripheral receptors. (2007) (5)
- Tramadol interaction with fluoxetine: An isobolographic analysis (2004) (5)
- D 2-dopamine receptor and cx , radrenoreceptor-mediated analgesic response of quercetin (2012) (5)
- Yohimbine potentiates the anticataleptic action of clonidine against perphenazine-induced catalepsy in rats. (1986) (5)
- Despair behaviour: a tool in experimental psychopharmacology. A review. (1986) (5)
- Evaluation of antiinflammatory and antihyperalgesic activity of some novel monocyclic β-lactam compounds in rats (2004) (5)
- 2-Naphthyloxy Derivatives Of N,N-Substituted Acetamides : Synthesis And Pharmacological Evaluation (2004) (5)
- Nitric oxide-releasing NSAIDs: A new dimension in nonsteroidal antiinflammatory drugs (2001) (5)
- Current concepts in cannabinoid pharmacology (2001) (5)
- Chronic electroconvulsive shock alters hypothermic response of B‐HT 920 and SKF 38393 in rats (1991) (5)
- The protective effect of adenosinergic agents, Ro 5-4864 and carbamazepine against hypoxic stress-induced neurotoxicity in mice. (1990) (4)
- An activity model for novel antidepressants that interact with the serotonin transporter (SERT). (2011) (4)
- Modulatory effect of alpha2 adrenoceptor agonists on Ro 5-4864-induced convulsions in rats and mice (2005) (4)
- Differential effect of the PDE5 inhibitors, sildenafil and zaprinast, in aging‐ and lipopolysaccharide‐induced cognitive dysfunction in mice (2004) (4)
- GABAergic, dopaminergic and cholinergic interaction in tremorine-induced tremors in mice. (1988) (4)
- Age-related susceptibility to chronic haloperidol-induced orofacial dyskinesia : Biochemical and neurochemical evidence (2007) (4)
- Involvement of dopamine D2 and 5-HT1A receptors in roxindole-induced antinociception. (1999) (4)
- The Antimuscarinic Activity of Clozapine in Rats (1996) (4)
- POTENTIAL MECHANISMS OF NEUROSTEROID-INDUCED ATTENUATION OF MORPHINE TOLERANCE AND DEPENDENCE (1998) (4)
- Modulatory effect of diclofenac on antispasmodic effect of pitofenone in cholinergic spasm. (2004) (4)
- α2‐Adrenoceptor‐and D2‐dopamine receptor‐mediated analgesic response of B‐HT 920 (1991) (4)
- Baclofen analgesia in mice: a GABAB-mediated response. (1991) (3)
- 5-HT3 RECEPTORS : A REVIEW OF THEIR PHARMACOLOGIC AND THERAPEUTIC ASPECTS (1996) (3)
- Benzodiazepine inverse agonist, DMCM- and peripheral agonist, Ro 5-4864-induced convulsions in mice: effect of adenosinergic agents. (1990) (3)
- On the D1 and D2 dopamine receptor participation in learning and memory in mice (1993) (3)
- Binding pattern of [35S]t-butylbicyclophosphorothionate is not altered following electroconvulsive shock treatment in rats (1989) (3)
- Differential role of dopamine D1 and D2 receptors in isoniazid-induced vacuous chewing movements. (2000) (3)
- Modulatory Effect of Nimesulide on Apomorphine Induced Stereotypy cind MK-801 Induced Hyperlocomotion (2005) (3)
- Rat anococcygeus: a dynamic smooth muscle preparation for experimental pharmacology. (1994) (3)
- SGLT2 Inhibitors: A New Generation of Antidiabetic Drugs (2015) (3)
- OXIDATIVE STRESS AND TARDIVE DYSKINESIA: ROLE OF NATURAL ANTIOXIDANTS (2004) (3)
- Effect of chronic treatment of Ro 15-1788 and its withdrawal on cortical and hippocampal EEG activity in rats. (1990) (3)
- GABAergic agents and clonidine attenuate footshock-induced aggression in mice. (1989) (2)
- Effect of D1- and D2-dopamine agonists on neocortical and hippocampal EEG activity of rat brain: modulation of rimcazole effect. (1993) (2)
- Effect of MK-801 and its interaction with adenosinergic agents and carbamazepine against hypoxic stress-induced convulsions and death in mice. (1990) (2)
- Reversal of Diazepam Tolerance and Withdrawal-induced Hyper Locomotor Activity and Anxiety by Melatonin in Mice (2006) (2)
- Involvement of normal physiological mechanisms in mediation of satiety by polyherbal antiobesity preparation, OB-200G, in female mice. (2003) (2)
- New therapeutic promises in the treatment of depression and schizophrenia. (2008) (2)
- Possible mechanism of digoxin-induced convulsions (2004) (2)
- Feverfew: ancient remedy for multiple disorders (1999) (2)
- INVOLVEMENT OF NEUROSTEROID MECHANISM IN THE ADRENOCORTICOTROPHIN-INDUCED BEHAVIORAL EFFECTS IN RATS (1998) (2)
- Modification by tricyclic antidepressants of cortical EEG changes induced by clonidine in conscious rats. (1986) (2)
- Modulatory role of nitric oxide and cyclooxygenase enzyme pathway in LPS-mediated hyperalgesia (2001) (2)
- SPIRULINA-INDUCED HYPERLOCOMOTOR ACTIVITY AND STEREOTYPY IN MICE (1996) (2)
- Nutritional supplement of lutein attenuates dopaminergic neurodegeneration induced by rotenone in rats (2014) (2)
- Nitecapone and selegiline as effective adjuncts to L-DOPA in reserpine-induced catatonia in mice. (2002) (2)
- N‐Methyl‐d‐Aspartate Receptor Participation in Parkinson's Disease, a Neurodegenerative Disorder (1995) (1)
- Research Article Rofecoxib potentiates the anticonvulsant effect of topiramate (2008) (1)
- Studies on the effect of ascorbic acid, zinc sulphate and their combination on carrageenan-induced oedema in rats. (1986) (1)
- Recent trends in information storage mechanisms (1992) (1)
- Altered response to GABAergic agents following electro and chemo convulsions in mice. (1991) (1)
- Concurrent outbreak of Cholera and Shigella in Ronihal village, Bijapur, Karnataka, India, 2016 (2020) (1)
- Hypocholesterolemic activity of some novel azetidin-2-ones in diet and diabetes induced hypercholesterolemia in rats. (2005) (1)
- Modification by clonidine of harmine-induced tremors in mice: involvement of serotoninergic system. (1986) (1)
- FACULTY DEVELOPMENT PROGRAMME FOR PHARMACY TEACHERS (1996) (1)
- Anticatatonic effect of clonidine: its interaction with dopaminergic, anticholinergic and GABA-ergic drugs. (1986) (1)
- Apparent pA2 estimates for an antinociceptive receptor. (1985) (1)
- O-14-6 GABA-A receptor mediated antistress activity of neurosteroids in mice (1996) (1)
- Failure of hydrocortisone and 2% saline treatment to abolish morphine and stress-induced analgesia in rats. (1983) (1)
- The new super C oxibs : The new super aspirins or unsafe pain k illers ? Educational Forum (1)
- Behavioral pharmacology of melatonin. (1998) (1)
- Simple ammonium salts acting on sigma-1 receptors yield potential treatments for cancer and depression (2020) (0)
- Anticatatonic effect of venoruton. (1988) (0)
- Effect of NMDA-receptor ligands on neocortical and hippocampal EEG activity of rat brain. (1991) (0)
- Autonomic hyperactivity on diazepam withdrawal in rats. (1987) (0)
- Key Role of Post-emptive PPAR-γ Activation in Extenuating Pain Hypersensitivity in Mononeuropathic Rats (2021) (0)
- Antiepileptic Actions of Barbiturates (2019) (0)
- Reviews: Cyclooxygenase in epilepsy: from perception to application. (2009) (0)
- On the characterization of dopamine-induced contractile response of rat anococcygeus muscle preparation. (1994) (0)
- 10th Symposium of the Austrian Pharmacological Society (APHAR) (2004) (0)
- On the convulsant action of DMCM and Ro 5-4864 in mice. (1988) (0)
- Regulatory Requirements and Quality Standards in India’s Clinical Trials Journey (2021) (0)
- Studies on the neuropsychopharmacological profile of fengabine (SL 79229) in mice. (1988) (0)
- MPTP: a pharmacological tool to study parkinsonism. (1986) (0)
- 2593 – DRUG METABOLISM INHIBITORS FROM THE SEA (1978) (0)
- Antagonism by naloxone of anti-tremorine effect of bromocriptine in mice. (1987) (0)
- ANTIDEPRESSANT DRUGS IN DISEASES OTHER THAN MENTAL DEPRESSION (1997) (0)
- NATIONAL WORKSHOP ON CLINICAL RESEARCH AND REGULATORY AFFAIRS - AN UPDATE (2005) (0)
- Modulation of various central neurotransmitter systems and perphenazine-induced catalepsy in rats. (1987) (0)
- Morphine-like effects of alpha 2 adrenergic agonists on cortical EEG in rats. (1986) (0)
- Modulatory effect of alpha 2 adrenoceptor agonists on Ro 5-4864-induced convulsions in rats and mice. (1987) (0)
- Selective cyclooxygenase-2 inhibitors in inflammatory bowel disease (2004) (0)
- Studies on starvation and dehydration-induced analgesia in rats. (1982) (0)
- Alpha2 agonists and GABAergic agents reverse isoniazid‐induced convulsions in mice (1989) (0)
- Subject Index Vol. 69, 2003 (2003) (0)
- Author Index 9th APHAR Symposium (2003) (0)
- Attenuation of reserpine-induced perioral movements and memory dysfunction by natural antioxidants (2010) (0)
- Alpha 2 adrenoceptor-mediated contraction of frog rectus abdominis muscle. (1984) (0)
- Pharmacologically active substances from the sea, II. Various cardiovascular activities found in the extracts of marine organisms. (1977) (0)
- PHARMACEUTICAL EDUCATION IN INDIA (1998) (0)
- Involvement of postsynaptic adrenergic mechanism(s) in the ATP-contractions of the rat anococcygeus muscle and the effect of extracellular Ca2+. (1988) (0)
- Developments in Psychopharmacology (2007) (0)
- Protective Effect Of Bupropion On Alcohol Abstinence-Induced Anxiety And Convulsions (2005) (0)
- Modulatory role of nitric oxide releasing NSAIDs in aging- and lipopolysaccharide-induced cognitive dysfunction in mice (2010) (0)
- PHARMACEUTICAL GRAND ROUND (1996) (0)
- GABAB receptors and phaclofen. (1989) (0)
- NEWER DEVELOPMENTS IN PSYCHOTROPIC AGENTS (1996) (0)
- Contents Vol. 69, 2003 (2003) (0)
- Antinociceptive action of FK506 in mice. (2003) (0)
- PREVENTION BY BR-16A OF GABA/BZ RECEPTOR MEDIATED TRIAZOLAM WITHDRAWAL REACTION IN MICE (1997) (0)
- Studies on meperidine-induced catalepsy in mice. (1987) (0)
- The Art of Ageing (2014) (0)
- Gaba-B receptors and nociception (1994) (0)
- Antinociceptive action of FK 506 in mice (2012) (0)
- Nimesulide, a cyclooxygenase-2 (COX-2) inhibitor counteracts immobilization stress-induced alterations in different behavioral and biochemical parameters in mice (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Shrinivas Krishnarao Kulkarni?
Shrinivas Krishnarao Kulkarni is affiliated with the following schools:
